VistaGen Therapeutics (VTGN)
(Delayed Data from NSDQ)
$3.84 USD
-0.07 (-1.79%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $3.81 -0.03 (-0.78%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.41 | -1.23% |
Earnings Summary
For their last quarter, VistaGen Therapeutics (VTGN) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.34 per share. This reflects a positive earnings surprise of 26.47%. Look out for VTGN's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year increase of 56.38%.
Earnings History
Price & Consensus
Zacks News for VTGN
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
VTGN: What are Zacks experts saying now?
Zacks Private Portfolio Services